20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7857 | DO1 | Disperse Orange 1 | Others |
DO1 (Disperse Orange 1) is an anti-amyloid agent which potently delays both seeded and non-seeded Aβ42 polymerization at substoichiometric concentrations | |||
T11901 | IDO1-IN-5 | IDO , Indoleamine 2,3-Dioxygenase (IDO) | |
IDO1-IN-5 is a selective, potent and brain penetrated inhibitor of IDO1 activity, binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1. | |||
T20513 | IDO1-IN-1 | IDO1 inhibitor 1,2 HzBTZ,IDO1IN1,2-HzBTZ,IDO1-inhibitor-1 | IDO |
IDO1-IN-1 (2 HzBTZ) is an indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor. | |||
T61789 | IDO1-IN-14 | ||
IDO1-IN-14 (compound 4a) is a highly effective inhibitor of the IDO1 enzyme, exhibiting an IC50 value of 396.9 nM. Additionally, IDO1-IN-14 demonstrates excellent suppression of cellular IDO1 activity, as observed in HeL... | |||
T63034 | IDO1-IN-13 | ||
IDO1-IN-13 (compound 27a) is a potent inhibitor of IDO1 (IC50: 61.6 nM). Ido1-in-13 inhibits cell IDO1 with an EC50 value of 30 nM for HeLa. In SK-OV-3 xenograft tumor tissue, IDO1-IN-13 reduced kyn/trp ratio by 51%. | |||
T63222 | IDO1/2-IN-1 | ||
IDO1/2-IN-1 is the first potent, orally active dual IDO1/IDO2 inhibitor, exhibiting antitumor effects with IC50s of 28 nM and 144 nM for IDO1 and IDO2, respectively. | |||
T78687 | IDO1-IN-21 | Indoleamine 2,3-Dioxygenase (IDO) | |
IDO1-IN-21 (compound 10m), with an IC50 of 0.64 μM, acts as an IDO1 inhibitor and has demonstrated efficacy in suppressing tumor growth in murine models [1]. | |||
T61944 | IDO1-IN-15 | ||
IDO1-IN-15 is an effective IDO1 inhibitor with IC50 of 127 nM. The potency of IDO1-IN-15 against IDO1 enzyme is comparable with Epacadostat in vitro. | |||
T12668 | (Rac)-IDO1-IN-5 | Others | |
(Rac)-IDO1-IN-5 is a racemate of IDO1-IN-5, a potent, selective, and brain-penetrating inhibitor of Indoleamine 2,3-Dioxygenase 1 (IDO1) activity. It specifically binds to apo-IDO1, which lacks heme, instead of mature he... | |||
T61385 | IDO1/TDO-IN-1 | ||
IDO1/TDO-IN-1 (30) is a highly effective inhibitor that targets both IDO1 and TDO enzymes with uncompetitive (Ki = 0.23 μM) and competitive (Ki = 0.73 μM) mechanisms, respectively. This compound, IDO1/TDO-IN-1 (30), exhi... | |||
T62638 | IDO1-IN-18 | ||
IDO1-IN-18 (Compound 14) is a potent inhibitor of IDO1. IDO1-IN-18 has potential for cancer disease research. | |||
T11625 | IDO1 and HDAC1 Inhibitor | Others | |
IDO1 and HDAC1 Inhibitor is a dual IDO1 and HDAC1 inhibitor (IC50s: 69.0 nM and 66.5 nM). | |||
T39946 | IDO1-IN-12 | IDO1-IN-12 | |
IDO1-IN-12 is a potent and orally available IDO1 inhibitor. | |||
T78795 | IDO1/TDO-IN-6 | Indoleamine 2,3-Dioxygenase (IDO) | |
IDO1/TDO-IN-6 (compound 11) is a dual inhibitor targeting IDO1 and TDO, exhibiting IC50 values of 2.25 μM for IDO1 and 2.89 μM for TDO. The compound further demonstrates Ki values of 1.9 μM for IDO1 and 3.1 μM for TDO, m... | |||
T73111 | IDO1-IN-17 | ||
IDO1-IN-17 (I-4) is an IDO1 inhibitor, with an IC 50 of 0.44 μM in hela cells . | |||
T11624 | IDO1-IN-2 | IDO | |
IDO1-IN-2 is a potent and selective IDO1 inhibitor with IC50s of 81 nM, 59 nM (mouse), and 28 nM (rat), respectively. It has anti-cancer activity. | |||
T60318 | IDO1/TDO-IN-4 | ||
IDO1/TDO-IN-4 displays potent inhibition of both IDO1 (IC50 = 3.53 μM) and TDO (IC50 = 1.15 μM) and has an acceptable safety profile and pharmacokinetic properties. IDO1/TDO-IN-4 forms a hydrogen bond with IDO1, and π π ... | |||
T78975 | IDO1-IN-22 | Indoleamine 2,3-Dioxygenase (IDO) | |
IDO1-IN-22 (Compound 3) is an inhibitor of IDO1, demonstrating potent activity with biochemical hIDO1 IC50 of 67.4 nM and HeLa hIDO1 IC50 of 17.6 nM. It exhibits excellent antitumor efficacy in an LLC xenograft model and... | |||
T63082 | IDO1-IN-19 | ||
IDO1-IN-19 (Compound 17) is a potent inhibitor of IDO1 and has potential for cancer disease research. | |||
T63780 | IDO1-IN-16 | ||
IDO1-IN-16 (I-1) is an IDO1 inhibitor that targets holo-IDO1 (IC50: 127 nM). |